Aquestive Therapeutics, Inc.

By person

23 insiders · 72 transactions

4.7×

Daniel Barber holds only 4.7 times base salary in stock. $3.14M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BRATTON DOUGLAS K

10% owner

$2.48M (1)

—

+$2.48M

2,161,004

1.72%

$10.41M

−43.0%

Barber Daniel

President and CEO

$104.05K (3)

$1.77M (9) scheduled

−$1.67M

652,317

0.5197%

$3.14M

+714.7%

Schobel Alexander Mark

Chief Innovation/Tech Officer

$79.45K (4)

$1.62M (9)

−$1.54M

984,476

0.7844%

$4.74M

−2.4%

Jung Cassie

Chief Operating Officer

—

$975.90K (4) scheduled

−$975.90K

208,833

0.1664%

$1.01M

+502.6%

Boyd Peter E.

Chief People Officer

$13.53K (5)

$336.91K (4) scheduled

−$323.38K

284,024

0.2263%

$1.37M

+472.0%

TOTH A ERNEST JR

Chief Financial Officer

—

$243.09K (1)

−$243.09K

283,460

0.2258%

$1.37M

—

Kraus Carl N

Chief Medical Officer

—

$141.90K (1) scheduled

−$141.90K

282,475

0.2251%

$1.36M

—

Kendall Keith J

CEO and President

$121.18K (9)

$255.31K (1)

−$134.13K

639,149

0.5092%

$3.08M

+4.4%

Krop Julie

Director

—

$125.39K (1) scheduled

−$125.39K

0.0000%

$0.00

—

Maxwell John T.

SVP-Chief Financial Officer

$142.35K (2)

$24.00K (1)

+$118.35K

150,614

0.1200%

$725.88K

+8.7%

Korczynski Sherry

Chief Commercial Officer

—

$111.36K (2)

−$111.36K

235,689

0.1878%

$1.14M

+371.4%

Cioffi Melina

SVP, Regulatory Affairs

—

$105.62K (1)

−$105.62K

273,200

0.2177%

$1.32M

+49.9%

Scibetta James S

Director

$86.98K (3)

—

+$86.98K

31,635

0.0252%

$152.46K

+265.1%

BRAENDER LORI J

Corporate Secretary

$86.15K (4)

$167.35K (1)

−$81.19K

231,042

0.1841%

$1.11M

—

Marshall Ken W.

SVP, Chief Commercial Officer

$14.67K (1)

—

+$14.67K

151,445

0.1207%

$729.89K

—

Wood Theresa

SVP-HR and Org. Development

$9.16K (2)

—

+$9.16K

80,765

0.0643%

$389.25K

+1.9%

Wargacki Stephen

Chief Science Officer

—

343,552

0.2737%

$1.66M

+1,722%

Zalewski Thomas A.

Chief Legal Officer

—

100,000

0.0797%

$481.95K

—

Davis Matthew W.

Chief Development Officer

—

100,000

0.0797%

$481.95K

—

Cochran John

Director

—

99,486

0.0793%

$479.47K

+32.5%

BROWN GREGORY B

Director

—

75,085

0.0598%

$361.87K

0.0%

Greenhawt Matthew J.

Chief Medical Officer

—

75,000

0.0598%

$361.46K

—

COSTA SANTO J

Director

—

17,327

0.0138%

$83.51K

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Barber Daniel

15 Sep 2026

President and CEO

Sold on a plan

25,000

$4.82

$120.49K

Barber Daniel

17 Aug 2026

President and CEO

Sold on a plan

25,000

$4.29

$107.17K

Barber Daniel

16 Jul 2026

President and CEO

Sold on a plan

20,369

$4.00

$81.51K

Barber Daniel

15 Jul 2026

President and CEO

Sold on a plan

4,631

$4.03

$18.68K

Barber Daniel

15 Jun 2026

President and CEO

Sold on a plan

25,000

$4.16

$104.01K

Barber Daniel

15 May 2026

President and CEO

Sold on a plan

8,257

$4.29

$35.41K

Boyd Peter E.

15 Oct 2025

See Remarks

Sold on a plan

10,000

$7.00

$70.00K

Kraus Carl N

15 Oct 2025

Chief Medical Officer

Sold on a plan

20,272

$7.00

$141.90K

Boyd Peter E.

26 Sep 2025

See Remarks

Sold on a plan

10,000

$6.30

$63.00K

Barber Daniel

26 Sep 2025

President and CEO

Sold on a plan

91,343

$6.03

$551.19K

Barber Daniel

19 Sep 2025

President and CEO

Sold on a plan

400

$6.00

$2.40K

Boyd Peter E.

5 Sep 2025

See Remarks

Sold on a plan

15,000

$5.30

$79.50K

Schobel Alexander Mark

15 Mar 2024

Chief Innovation/Tech Officer

Sold on a plan

50,000

$6.00

$300.00K

Schobel Alexander Mark

8 Mar 2024

Chief Innovation/Tech Officer

Sold on a plan

25,000

$5.19

$129.69K

Show all 72 transactions →

Aquestive Therapeutics, Inc.

By person

Individual transactions

What was left out